Astellas Pharma US, Inc., is the U.S. affiliate of Astellas Pharma Inc., a R&D-driven global pharmaceutical company. At Astellas, we improve lives through innovative and effective medicines. Our dedication to changing tomorrow for patients and our customers fits closely with our strong scientific orientation and focus on the community in which we work and live.

Research Grants 97 show all


$1.8M
2009

$11M
2012

$9.6M
2013

$7.9M
2014

$6M
2015

Publications 1,207 show all

  • 34
    Tacrolimus/pharmacology
  • 33
    Nifedipine/analogs & derivatives
  • 30
    Enzyme Inhibitors/pharmacology
  • 30
    Immunosuppressive Agents/pharmacology
  • 26
    Anti-Bacterial Agents/pharmacology
  • 25
    Pyridines/pharmacology
  • 23
    Indoles/pharmacology
  • 23
    Streptomyces/metabolism
  • 21
    Pyrazoles/pharmacology
  • 20
    Peptides, Cyclic/pharmacology

Patents 20,957show all

  • 5,795
    C07D - Heterocyclic compounds
  • 3,755
    A61K - Preparations for medical, dental, or toilet purposes
  • 994
    C07K - Peptides
  • 854
    C07C - Acyclic or carbocyclic compounds
  • 644
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 402
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 307
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 303
    C12N - Microorganisms or enzymes
  • 225
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 193
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 2,075show all

552N/A441Phase 3353Phase 2321Phase 1242Phase 456Other

Contact Information

Chūō
Japan